Replies to post #161599 on Bioelectronics Corp (BIEL)

[markjohn62]

As per your post they haven't submitted it yet, lol. This was all about you saying it was filled already. They are applying for the innovation challenge. After that they will submit recovery Rx 510k for post surgical pain. I am done with this topic. Carry on.

[shadolane]

Yes, then another 180 day wait or whatever.

I'd be trying to sell everywhere else where there are no obstacles.

[GetSeriousOK]

(1) The link you posted said the Recruiting Status is "Recruiting," and the "Estimated Study Completion Date" is December 30th. If the Study ends on schedule (which is unlikely, considering the history of BIEL's clinicals all taking longer than planned), they still have to analyze the data. No WAY that study gets submitted to the FDA in "a few weeks." More like "a few months."

https://clinicaltrials.gov/ct2/show/NCT03604068

(1b) this study is for "post-operative pain," not wound healing.

(2) "BIEL received clinical trials from another site?" Let's see those clinical trials. I'll believe them when I see them.

(3) "as per company" means NOTHING to anyone who has been following this stock for the past few years. For example, the back study data was good, "as per company." Notice, however, that the company never revealed that data.

Why didn't BIEL reveal the study data from that Back Study? Where's the data from their other 2017 and 2018 studies?